IN2012DN02576A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02576A IN2012DN02576A IN2576DEN2012A IN2012DN02576A IN 2012DN02576 A IN2012DN02576 A IN 2012DN02576A IN 2576DEN2012 A IN2576DEN2012 A IN 2576DEN2012A IN 2012DN02576 A IN2012DN02576 A IN 2012DN02576A
- Authority
- IN
- India
- Prior art keywords
- oxaliplatin
- nanoparticle
- mixed
- supercritical fluid
- mixture solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090089079 | 2009-09-21 | ||
| PCT/KR2010/006459 WO2011034394A2 (fr) | 2009-09-21 | 2010-09-20 | Nanoparticules d'oxaliplatine et leur procédé de préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02576A true IN2012DN02576A (fr) | 2015-08-28 |
Family
ID=43759199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2576DEN2012 IN2012DN02576A (fr) | 2009-09-21 | 2010-09-20 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9393201B2 (fr) |
| EP (1) | EP2481396A4 (fr) |
| JP (1) | JP5759464B2 (fr) |
| KR (1) | KR101396461B1 (fr) |
| CN (1) | CN102665689B (fr) |
| AU (1) | AU2010296180B2 (fr) |
| CA (1) | CA2774669C (fr) |
| IN (1) | IN2012DN02576A (fr) |
| MX (1) | MX348668B (fr) |
| RU (1) | RU2563997C2 (fr) |
| WO (1) | WO2011034394A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201591725A1 (ru) | 2013-03-15 | 2016-01-29 | ДСМ АйПи АССЕТС Б.В. | Твердые липидные наночастицы (ii) |
| CN109152745A (zh) * | 2017-04-21 | 2019-01-04 | 株式会社生物研究 | 利用脂质作为研磨工序中的润滑剂的制备活性物质纳米粒子的方法 |
| KR101895237B1 (ko) * | 2017-06-12 | 2018-09-07 | 목포대학교산학협력단 | 옥살리플라틴을 포함하는 경구용 약물전달 조성물 및 이의 제조방법 |
| KR102184117B1 (ko) * | 2017-10-31 | 2020-11-30 | 주식회사 삼양바이오팜 | 수용해도 및 생체이용율이 개선된 소라페닙 나노입자 경구용 조성물 및 이의 제조 방법 |
| ES2927608T3 (es) | 2018-09-14 | 2022-11-08 | Inst Nat Sante Rech Med | Sistema de liberación de fármacos para fármacos basados en platino |
| CN110917345B (zh) * | 2019-09-26 | 2021-11-09 | 苏州百迈生物医药有限公司 | 一种化疗免疫组合药物及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ286714B6 (en) | 1994-08-08 | 2000-06-14 | Debiopharm Sa | Pharmaceutically stable preparation based on oxaliplatinum |
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| DK0975329T3 (da) * | 1997-02-05 | 2005-03-14 | Upjohn Co | Lipidkomplekser af yderst uoplöselige platinkomplekser |
| GB9804013D0 (en) | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
| US7217735B1 (en) * | 1999-04-09 | 2007-05-15 | Au Jessie L-S | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| AU777620B2 (en) * | 1999-04-09 | 2004-10-21 | Jessie L.S. Au | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| AU2002223013A1 (en) | 2000-12-12 | 2002-06-24 | Debiopharm S.A. | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
| US6476068B1 (en) | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
| US20050090544A1 (en) | 2003-08-28 | 2005-04-28 | Whittaker Darryl V. | Oxaliplatin formulations |
| KR100603974B1 (ko) * | 2003-12-05 | 2006-07-25 | 김갑식 | 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법 |
| CN1775216A (zh) * | 2004-11-15 | 2006-05-24 | 胡才忠 | 一种新型的制剂——奥沙利铂脂质体 |
| DE102005011786A1 (de) * | 2005-03-11 | 2006-09-14 | Pharmasol Gmbh | Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen |
| RS20080167A (en) * | 2005-10-21 | 2009-07-15 | Panacea Biotec Limited, | Novel improved compositions for cancer therapy |
| KR20070067768A (ko) | 2005-12-23 | 2007-06-29 | 주식회사 삼양사 | 안정한 옥살리플라틴 조성물 및 이의 제조방법 |
| GR20060100144A (el) | 2006-03-03 | 2007-10-17 | Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene | |
| WO2007129829A1 (fr) * | 2006-05-04 | 2007-11-15 | Bio-Synectics Inc. | Procédé de préparation de nanoparticules de matière active |
| KR101342119B1 (ko) * | 2006-05-04 | 2013-12-18 | (주)바이오시네틱스 | 디올 화합물을 이용한 나노수준의 활성물질 입자 제조 방법 |
| CN1868455A (zh) * | 2006-05-20 | 2006-11-29 | 沈阳药科大学 | 奥沙利铂磷脂复合物静脉给药的纳米混悬注射剂 |
| KR100913063B1 (ko) | 2006-09-13 | 2009-08-21 | 주식회사유한양행 | 옥살리플라틴-함유 주사용 용액 |
| JP2010515493A (ja) * | 2007-01-12 | 2010-05-13 | ヤンファン リー， | Ｘ線不透過性生物分解微小球型血管栓塞材料 |
| CN100563646C (zh) * | 2007-07-13 | 2009-12-02 | 陈祥峰 | 一种奥沙利铂脂质体葡萄糖制剂的制备方法 |
| CN101809024A (zh) * | 2007-07-16 | 2010-08-18 | 铂雅制药公司 | 吡铂的口服制剂 |
-
2010
- 2010-09-20 JP JP2012530778A patent/JP5759464B2/ja not_active Expired - Fee Related
- 2010-09-20 CN CN201080052369.7A patent/CN102665689B/zh not_active Expired - Fee Related
- 2010-09-20 WO PCT/KR2010/006459 patent/WO2011034394A2/fr active Application Filing
- 2010-09-20 US US13/497,208 patent/US9393201B2/en not_active Expired - Fee Related
- 2010-09-20 CA CA2774669A patent/CA2774669C/fr not_active Expired - Fee Related
- 2010-09-20 MX MX2012003393A patent/MX348668B/es active IP Right Grant
- 2010-09-20 IN IN2576DEN2012 patent/IN2012DN02576A/en unknown
- 2010-09-20 KR KR1020127003342A patent/KR101396461B1/ko active IP Right Grant
- 2010-09-20 RU RU2012116085/15A patent/RU2563997C2/ru not_active IP Right Cessation
- 2010-09-20 AU AU2010296180A patent/AU2010296180B2/en not_active Ceased
- 2010-09-20 EP EP10817463.2A patent/EP2481396A4/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012116085A (ru) | 2013-10-27 |
| MX348668B (es) | 2017-06-23 |
| US20120177728A1 (en) | 2012-07-12 |
| CN102665689B (zh) | 2015-04-22 |
| JP2013505291A (ja) | 2013-02-14 |
| US9393201B2 (en) | 2016-07-19 |
| EP2481396A2 (fr) | 2012-08-01 |
| EP2481396A4 (fr) | 2014-03-05 |
| WO2011034394A3 (fr) | 2011-11-03 |
| MX2012003393A (es) | 2012-07-25 |
| CA2774669C (fr) | 2017-12-19 |
| JP5759464B2 (ja) | 2015-08-05 |
| WO2011034394A2 (fr) | 2011-03-24 |
| AU2010296180B2 (en) | 2016-05-05 |
| AU2010296180A1 (en) | 2012-04-19 |
| KR101396461B1 (ko) | 2014-05-20 |
| KR20120046243A (ko) | 2012-05-09 |
| CA2774669A1 (fr) | 2011-03-24 |
| CN102665689A (zh) | 2012-09-12 |
| RU2563997C2 (ru) | 2015-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02576A (fr) | ||
| MX2011006771A (es) | Metodo de preparacion de una composicion de micelas polimericas que contienen un farmaco pobremente soluble en agua. | |
| MX2010010647A (es) | Proceso para preparar formulaciones de dabigatran para administracion oral. | |
| MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| WO2013093648A3 (fr) | Procédé de fabrication de nanoparticules lipidiques pour une administration de médicament | |
| MY154015A (en) | A hydrogen halide complex of agomelatine and preparation thereof | |
| MY194905A (en) | Processes and Intermediates for Preparing a Medicament | |
| CN102827153B (zh) | 阿齐沙坦的晶型及其制备方法 | |
| WO2007005633A3 (fr) | Procede de preparation d'une forme posologique liquide contenant du 4-phenylbutyrate de sodium | |
| MY167395A (en) | Method for producing glufosinate p free acid | |
| WO2010045281A3 (fr) | Formulations aqueuses stables de medicaments insolubles ou peu solubles dans l'eau | |
| AR079580A1 (es) | Procesos para la fabricacion de un agente farmaceuticamente activo | |
| GB2505859A8 (en) | Aripiprazole type I microcrystal, aripiprazole solid preparation, and preparation method | |
| CN104586758B (zh) | 一种对乙酰氨基酚注射液及其制备方法 | |
| CN103989677A (zh) | 去亚甲基小檗碱在制备降血糖药物中的应用 | |
| MX2020001760A (es) | Composicion farmaceutica que incluye un comprimido esferoide de multiples unidades que contiene esomeprazol y una sal farmaceuticamente aceptable esferoide de este, y metodo para preparar la composicion farmaceutica. | |
| MX2013012204A (es) | Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas. | |
| MY160337A (en) | Agomelatine hydrobromide hydrate and preparation thereof | |
| CN103751104A (zh) | 依达拉奉注射液及其制备方法 | |
| WO2012145555A3 (fr) | Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci | |
| CN103860474A (zh) | 一种多西环素可溶性粉的制备方法 | |
| CN102406605A (zh) | 雄性激素类药物的醇质体制剂及其制备方法 | |
| CN102100668B (zh) | 高级脂肪酸衍生物微乳及其制备方法和应用 | |
| CN104840417A (zh) | 一种盐酸氨溴索注射液及其制备方法 | |
| CN109589303A (zh) | 一种氢化可的松环糊精包合物软膏的制备方法 |